Evidence map›Paper›PMID 26168294›Full record

ArticleNature medicine2015

Preconditioning allows engraftment of mouse and human embryonic lung cells, enabling lung repair in mice.

Chava Rosen, Elias Shezen, Anna Aronovich, Yael Zlotnikov Klionsky, Yasmin Yaakov, Miri Assayag, Inbal Eti Biton, Orna Tal, Guy Shakhar, Herzel Ben-Hur and 14 more

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Nature medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02705144 (Definition of the Status of the Human Lung Stem Cell Niches ex Vivo in Tissue Biopsies Performed in Patients With Emphysema and Interstitial Fibrosis Compared to Non-diseased Areas), which is not on this map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02705144 unknown statusnot on this mapstarted 2016, after this paper: background citation

Definition of the Status of the Human Lung Stem Cell Niches ex Vivo in Tissue Biopsies Performed in Patients With Emphysema and Interstitial Fibrosis Compared to Non-diseased Areas

TypeobservationalSponsorSheba Medical CenterRan2016 to 2019Enrolled20ConditionsLung Diseases, InterstitialArmsanalysis of the number of stem cell niches
3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 128 citations in OpenAlex.

  1. Article
  2. From Epithelium to Therapy: Transitional Cells in Lung Fibrosis.American journal of respiratory cell and molecular biology · 2025
    Review
  3. Article
  4. Review
  5. Lung stem cells and respiratory epithelial chimerism in transplantation.European respiratory review : an official journal of the European Respiratory Society · 2025
    Review
  6. Review
  7. Article
  8. Review
  9. Viral airway injury promotes cell engraftment in an in vitro model of cystic fibrosis cell therapy.American journal of physiology. Lung cellular and molecular physiology · 2024
    Article
  10. Article
  11. Article
  12. Rational engineering of lung alveolar epithelium.NPJ Regenerative medicine · 2023
    Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors at 3 institutions in 2 countries.

Chava RosenDepartment of Immunology, The Weizmann Institute of Science, Rehovot, Israel.
Elias ShezenDepartment of Immunology, The Weizmann Institute of Science, Rehovot, Israel.
Anna AronovichDepartment of Immunology, The Weizmann Institute of Science, Rehovot, Israel.
Yael Zlotnikov KlionskyDepartment of Immunology, The Weizmann Institute of Science, Rehovot, Israel.
Yasmin YaakovPediatric Gastroenterology, Hadassah Mt. Scopus Medical Center, Hebrew University, Jerusalem, Israel.
Miri AssayagPulmonary Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Inbal Eti BitonDepartment of Veterinary Resources, The Weizmann Institute of Science, Rehovot, Israel.
Orna TalDepartment of Immunology, The Weizmann Institute of Science, Rehovot, Israel.
Guy ShakharDepartment of Immunology, The Weizmann Institute of Science, Rehovot, Israel.
Herzel Ben-Hur1] Department of Obstetric and Gynecology, Assaf Harofeh Medical Center, Zerifin, Israel. [2] Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
David Shneider1] Department of Obstetric and Gynecology, Assaf Harofeh Medical Center, Zerifin, Israel. [2] Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Zvi Vaknin1] Department of Obstetric and Gynecology, Assaf Harofeh Medical Center, Zerifin, Israel. [2] Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Oscar Sadan1] Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. [2] Department of Obstetrics and Gynecology, Wolfson Medical Center, Tel Aviv, Israel.
Shmuel Evron1] Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. [2] Department of Anesthesiology, Wolfson Medical Center, Tel Aviv, Israel.
Enrique Freud1] Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. [2] Department of Pediatric Surgery, Schneider Children's Medical Center, Petach Tikvah, Israel.
David ShoseyovPediatric Pulmonology, Hadassah Mt. Scopus Medical Center Hebrew University, Jerusalem, Israel.
Michael WilschanskiPediatric Gastroenterology, Hadassah Mt. Scopus Medical Center, Hebrew University, Jerusalem, Israel.
Neville BerkmanPulmonary Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Willem E FibbeDepartment of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, the Netherlands.
David HaginDepartment of Immunology, The Weizmann Institute of Science, Rehovot, Israel.
Carmit Hillel-KarnielDepartment of Immunology, The Weizmann Institute of Science, Rehovot, Israel.
Irit Milman KrentsisDepartment of Immunology, The Weizmann Institute of Science, Rehovot, Israel.
Esther Bachar-LustigDepartment of Immunology, The Weizmann Institute of Science, Rehovot, Israel.
Yair ReisnerDepartment of Immunology, The Weizmann Institute of Science, Rehovot, Israel.
Weizmann Institute of Science · ILHadassah Medical Center · ILLeiden University Medical Center · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Repair of injured lungs represents a longstanding therapeutic challenge. We show that human and mouse embryonic lung tissue from the canalicular stage of development (20-22 weeks of gestation for humans, and embryonic day 15-16 (E15-E16) for mouse) are enriched with progenitors residing in distinct niches. On the basis of the marked analogy to progenitor niches in bone marrow (BM), we attempted strategies similar to BM transplantation, employing sublethal radiation to vacate lung progenitor niches and to reduce stem cell competition. Intravenous infusion of a single cell suspension of canalicular lung tissue from GFP-marked mice or human fetal donors into naphthalene-injured and irradiated syngeneic or SCID mice, respectively, induced marked long-term lung chimerism. Donor type structures or 'patches' contained epithelial, mesenchymal and endothelial cells. Transplantation of differentially labeled E16 mouse lung cells indicated that these patches were probably of clonal origin from the donor. Recipients of the single cell suspension transplant exhibited marked improvement in lung compliance and tissue damping reflecting the energy dissipation in the lung tissues. Our study provides proof of concept for lung reconstitution by canalicular-stage human lung cells after preconditioning of the pulmonary niche.

Indexed as

Transplantation ConditioningAnimalsBromodeoxyuridineEmbryonic Stem CellsFemaleHumansLungMaleMiceMice, Inbred C3HMice, Inbred C57BLMice, SCIDRegenerationTransplantation ChimeraTransplantation, HeterologousBromodeoxyuridine

Identifiers

PMID26168294
OpenAlexW909607896

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.